Journal: Journal of Inflammation Research
Article Title: Microglial Activation Mediates Noradrenergic Locus Coeruleus Neurodegeneration via Complement Receptor 3 in a Rotenone-Induced Parkinson’s Disease Mouse Model
doi: 10.2147/JIR.S299927
Figure Lengend Snippet: LA-1 abrogates rotenone-induced activation and M1 polarization of microglia in mice. ( A ) Immunohistochemistry with an anti-Iba-1 antibody was performed to stain microglial cells in the LC of rotenone-intoxicated mice with or without LA-1 treatment, and representative images are shown. ( B ) Quantification of the density of Iba-1 immunostaining. Results were mean ± SEM from five mice for each group and were analyzed by one-way ANOVA (F (3,16) = 10.109, P = 0.001). ( C ) The mRNA levels of iNOS, TNFα and IL-1β in the brainstem of rotenone-treated mice with or without LA-1 treatment were determined by real-time PCR. Results were mean ± SEM from five mice for each group and were analyzed by one-way ANOVA (iNOS: F (3,16) = 5.661, P = 0.008; TNFα: F (3,16) = 7.439, P = 0.002; IL-1β: F (3,16) = 3.589, P = 0.037; post hoc analysis by Tukey’s multiple comparisons test). ( D ) The mRNA levels of Arg-1, CD206 and YM-1 in the brainstem of rotenone-treated mice with or without LA-1 treatment were determined by real-time PCR. Results were mean ± SEM from five mice for each group and were analyzed by one-way ANOVA (Arg-1: F (3,16) = 12.575, P = 0.000, post hoc analysis by Tukey’s multiple comparisons test; CD206: F (3,16) = 6.956, P=0.003, post hoc analysis by Tamhane’s T2 multiple comparisons test; YM-1: F (3,16) = 10.109, P=0.001, post hoc analysis by Tukey’s multiple comparisons test). *P<0.05, **P<0.01; Scale bar = 100 μm.
Article Snippet: Mice received (i.p.) 500 μL of 50 μM LA-1 (S8306, Selleck, China) or vehicle 1 h after rotenone injection for 3 continuous weeks.
Techniques: Activation Assay, Immunohistochemistry, Staining, Immunostaining, Real-time Polymerase Chain Reaction